KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Amortizatization of Intangibles: 2018-2025

Historic Amortizatization of Intangibles for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $17.0 million.

  • Moderna's Amortizatization of Intangibles fell 19.05% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.0 million, marking a year-over-year decrease of 23.96%. This contributed to the annual value of $95.0 million for FY2024, which is 55.74% up from last year.
  • Latest data reveals that Moderna reported Amortizatization of Intangibles of $17.0 million as of Q3 2025, which was down 5.56% from $18.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Amortizatization of Intangibles registered a high of $28.0 million during Q2 2024, and its lowest value of -$21.0 million during Q4 2021.
  • For the 3-year period, Moderna's Amortizatization of Intangibles averaged around $19.1 million, with its median value being $19.0 million (2025).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first slumped by 700.00% in 2021, then soared by 400.00% in 2023.
  • Moderna's Amortizatization of Intangibles (Quarterly) stood at -$21.0 million in 2021, then soared by 119.05% to $4.0 million in 2022, then skyrocketed by 400.00% to $20.0 million in 2023, then declined by 5.00% to $19.0 million in 2024, then fell by 19.05% to $17.0 million in 2025.
  • Its Amortizatization of Intangibles stands at $17.0 million for Q3 2025, versus $18.0 million for Q2 2025 and $19.0 million for Q1 2025.